News
BVS
14.13
+1.04%
0.15
Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcy
Benzinga · 1d ago
Bioventus (BVS) Is Up 6.1% After Reaffirming 2026 Sales Outlook And Strong Q2 Earnings Jump
Simply Wall St · 1d ago
Bioventus: Buy Rating Reaffirmed on Growth Outlook, Financial Flexibility and Strategic Review; $15 Price Target Maintained
TipRanks · 2d ago
Bioventus price target raised to $18 from $16 at Craig-Hallum
TipRanks · 2d ago
Biotech Stocks At 52-Week Highs - BVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRS
NASDAQ · 2d ago
Bioventus (BVS) Stock Jumps On Profit Strength As Growth Risks Remain
Simply Wall St · 3d ago
Bioventus Reports Solid Q2 Results Amid Strategic Review
TipRanks · 3d ago
Bioventus Inc. Q2 Profit Advances
NASDAQ · 3d ago
Bioventus Non-GAAP EPS of $0.22 in-line, revenue of $153.2M misses by $2.44M
Seeking Alpha · 3d ago
Bioventus Q2 Adj. EPS $0.22, Inline, Sales $153.208M Miss $155.640M Estimate
Benzinga · 3d ago
*Bioventus Backs 2026 Sales $600M-$610M >BVS
Dow Jones · 3d ago
*Bioventus 2Q Adj EPS 22c >BVS
Dow Jones · 3d ago
*Bioventus 2Q Sales $153.2M >BVS
Dow Jones · 3d ago
Weekly Report: what happened at BVS last week (0727-0731)?
Weekly Report · 5d ago
Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRX
NASDAQ · 07/29 08:21
Weekly Report: what happened at BVS last week (0720-0724)?
Weekly Report · 07/27 10:23
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
Benzinga · 07/27 09:09
Weekly Report: what happened at BVS last week (0713-0717)?
Weekly Report · 07/20 10:20
Biotech Stocks At 52-Week Highs- CDNA, IART, AGL, BVS, ELVN
NASDAQ · 07/17 09:13
Weekly Report: what happened at BVS last week (0706-0710)?
Weekly Report · 07/13 10:22
More
Webull provides a variety of real-time BVS stock news. You can receive the latest news about Bioventus Inc. through multiple platforms. This information may help you make smarter investment decisions.
About BVS
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.